Unraveling Haplotype Diversity of the Apical Membrane Antigen-1 Gene in Plasmodium falciparum Populations in Thailand
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Development of an effective vaccine is critically needed for the prevention of malaria. One of the key antigens for malaria vaccines is the apical membrane antigen 1 (AMA-1) of the human malaria parasite Plasmodium falciparum, the surface protein for erythrocyte invasion of the parasite. The gene encoding AMA-1 has been sequenced from populations of P. falciparum worldwide, but the haplotype diversity of the gene in P. falciparum populations in the Greater Mekong Subregion (GMS), including Thailand, remains to be characterized. In the present study, the AMA-1 gene was PCR amplified and sequenced from the genomic DNA of 65 P. falciparum isolates from 5 endemic areas in Thailand. The nearly fulllength 1,848 nucleotide sequence of AMA-1 was subjected to molecular analyses, including nucleotide sequence diversity, haplotype diversity and deduced amino acid sequence diversity and neutrality tests. Phylogenetic analysis and pairwise population differentiation (Fst indices) were performed to infer the population structure. The analyses identified 60 single nucleotide polymorphic loci, predominately located in domain I of AMA-1. A total of 31 unique AMA-1 haplotypes were identified, which included 11 novel ones. The phylogenetic tree of the AMA-1 haplotypes revealed multiple clades of AMA-1, each of which contained parasites of multiple geographical origins, consistent with the Fst indices indicating genetic homogeneity or gene flow among geographically distinct populations of P. falciparum in Thailand’s borders with Myanmar, Laos and Cambodia. In summary, the study revealed novel haplotypes and population structure needed for the further advancement of AMA-1-based malaria vaccines in the GMS.
Abstract
Development of an effective vaccine is critically needed for the prevention of malaria. One of the key antigens for malaria vaccines is the apical membrane antigen 1 (AMA-1) of the human malaria parasite Plasmodium falciparum, the surface protein for erythrocyte invasion of the parasite. The gene encoding AMA-1 has been sequenced from populations of P. falciparum worldwide, but the haplotype diversity of the gene in P. falciparum populations in the Greater Mekong Subregion (GMS), including Thailand, remains to be characterized. In the present study, the AMA-1 gene was PCR amplified and sequenced from the genomic DNA of 65 P. falciparum isolates from 5 endemic areas in Thailand. The nearly fulllength 1,848 nucleotide sequence of AMA-1 was subjected to molecular analyses, including nucleotide sequence diversity, haplotype diversity and deduced amino acid sequence diversity and neutrality tests. Phylogenetic analysis and pairwise population differentiation (Fst indices) were performed to infer the population structure. The analyses identified 60 single nucleotide polymorphic loci, predominately located in domain I of AMA-1. A total of 31 unique AMA-1 haplotypes were identified, which included 11 novel ones. The phylogenetic tree of the AMA-1 haplotypes revealed multiple clades of AMA-1, each of which contained parasites of multiple geographical origins, consistent with the Fst indices indicating genetic homogeneity or gene flow among geographically distinct populations of P. falciparum in Thailand’s borders with Myanmar, Laos and Cambodia. In summary, the study revealed novel haplotypes and population structure needed for the further advancement of AMA-1-based malaria vaccines in the GMS.
참고문헌 (67)
- World Malaria Report, "World Heath Organization", World Heath Organization, ~ (2016)
- Fried M, "Malaria during Pregnancy", Cold Spring Harb Perspect Med, 7, pp.a025551~ (2017)[DOI]
- Maitland K, "Severe malaria in African children - the need for continuing investment", N Engl J Med, 375, pp.2416~2417 (2016)[DOI]
- Ashley EA, "Spread of artemisinin resistance in Plasmodium falciparum malaria", N Engl J Med, 371, pp.411~423 (2014)[DOI]
- Manske M, "Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing", Nature, 487, pp.375~379 (2012)[DOI]
- Mu J, "Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome", Nat Genet, 39, pp.126~130 (2007)[DOI]
- Triglia T, "Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species", Mol Microbiol, 38, pp.706~718 (2000)[DOI]
- Silvie O, "A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites", J Biol Chem, 279, pp.9490~9496 (2004)[DOI]
- Marshall VM, "Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum", Mol Biochem Parasitol, 77, pp.109~113 (1996)[DOI]
- Hodder AN, "The disulfide bond structure of Plasmodium apical membrane antigen-1", J Biol Chem, 271, pp.29446~29452 (1996)[DOI]
- Srinivasan P, "Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion", Proc Natl Acad Sci USA, 108, pp.13275~13280 (2011)[DOI]
- Howell SA, "Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1", J Biol Chem, 276, pp.31311~31320 (2001)[DOI]
- Dutta S, "Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites", Proc Natl Acad Sci USA, 100, pp.12295~12300 (2003)[DOI]
- Urquiza M, "Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein", Vaccine, 19, pp.508~513 (2000)[DOI]
- Treeck M, "Functional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion process", PLoS Pathog, 5, pp.e1000322~ (2009)[DOI]
- Sirima SB, "Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or <TEX>$Alhydrogel^{(R)}$<", TEX> in European and African adults: a phase 1a, Vaccine, pp.2017, 35[DOI]
- Payne RO, "Demonstration of the blood-stage Plasmodium falciparum controlled human malaria infection model to assess efficacy of the P. falciparum apical membrane antigen 1 vaccine, FMP2.1", AS01, 2016, pp.213, 1743~1751
- Sagara I, "A randomized controlled phase 2 trial of the blood stage AMA1-C1", Alhydrogel malaria vaccine in children in Mali, 2009, pp.27, 3090~3098
- ) in healthy Malian adults in Bandiagara, "Malaria J", 2016, 442~, 10.1186[DOI]
- Laurens MB, "Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial", PLoS One, 8, pp.e79323~ (2013)[DOI]
- Gardner MJ, "Genome sequence of the human malaria parasite Plasmodium falciparum", Nature, 419, pp.498~511 (2002)[DOI]
- Thera MA, "A Field Trial to Assess a Blood-Stage Malaria Vaccine", N Engl J Med, 365, pp.1004~1013 (2011)[DOI]
- Al-Qahtani AA, "Comparative sequence analysis of domain I of Plasmodium falciparum apical membrane antigen 1 from Saudi Arabia and worldwide isolates", Infect Genet Evol, 39, pp.381~388 (2016)[DOI]
- Basu M, "Natural selection and population genetic structure of domain-I of Plasmodium falciparum apical membrane antigen-1 in India", Infect Genet Evol, 18, pp.247~256 (2013)[DOI]
- Garg S, "Sequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populations", Malaria J, 6, pp.154~ (2007)[DOI]
- Mardani A, "Genetic diversity and natural selection at the domain I of apical membrane antigen-1 (AMA-1) of Plasmodium falciparum in isolates from Iran", Exp Parasitol, 130, pp.456~462 (2012)[DOI]
- Mehrizi AA, "Population genetics, sequence diversity and selection in the gene encoding the Plasmodium falciparum apical membrane antigen 1 in clinical isolates from the south-east of Iran", Infect Genet Evol, 17, pp.51~61 (2013)[DOI]
- Rajesh V Singamsetti VK, "Plasmodium falciparum: genetic polymorphism in apical membrane antigen-1 gene from Indian isolates", Exp Parasitol, 119, pp.144~151 (2008)[DOI]
- Arnott A, "Distinct patterns of diversity, population structure and evolution in the AMA-1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission", Malaria J, 13, pp.233~ (2014)[DOI]
- Cortes A, "Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA-1", Infect Immun, 71, pp.1416~1426 (2003)[DOI]
- Tanabe K, "Within-population genetic diversity of Plasmodium falciparum vaccine candidate antigens reveals geographic distance from a Central sub-Saharan African origin", Vaccine, 31, pp.1334~1339 (2013)[DOI]
- Duan JH, "Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design", Proc Natl Acad Sci USA, 105, pp.7857~7862 (2008)[DOI]
- Osier FH, "Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya", Infect Immun, 78, pp.4625~4633 (2010)[DOI]
- Ouattara A, "Lack of allele-specific efficacy of a bivalent AMA-1 malaria vaccine", Malaria J, 9, pp.175~ (2010)[DOI]
- Ouattara A, "Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications", J Infect Dis, 207, pp.511~519 (2013)[DOI]
- Polley SD, "Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene", Genetics, 158, pp.1505~1512 (2001)
- Soulama I, "Genetic diversity of polymorphic vaccine candidate antigens (apical membrane antigen- 1, merozoite surface protein-3, and erythrocyte binding antigen-175) in Plasmodium falciparum isolates from western and central Africa", Am J Trop Med Hyg, 84, pp.276~284 (2011)[DOI]
- Takala SL, "Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development", Sci Transl Med, 1, pp.2ra5~ (2009)
- Tetteh KK, "Prospective Identification of Malaria Parasite Genes under Balancing Selection", PLoS One, 4, pp.e5568~ (2009)[DOI]
- Escalante AA, "Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project", Mol Biochem Parasitol, 113, pp.279~287 (2001)[DOI]
- Ord RL, "AMA1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency", PLoS One, 3, pp.e3366~ (2008)[DOI]
- Tanabe K, "Plasmodium falciparum: Genetic diversity and complexity of infections in an isolated village in western Thailand", Parasitol Int, 64, pp.260~266 (2015)[DOI]
- Cui LW, "Malaria in the Greater Mekong Subregion: heterogeneity and complexity", Acta Trop, 121, pp.227~239 (2012)[DOI]
- Imwong M, "The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study", Lancet Infect Dis, 17, pp.491~497 (2017)[DOI]
- Polley SD, "Allele frequencybased analyses robustly map sequence sites under balancing selection in a malaria vaccine candidate antigen", Genetics, 165, pp.555~561 (2003)
- Zhu X, "Genetic diversity of the Plasmodium falciparum apical membrane antigen I gene in parasite population from the China-Myanmar border area", Infect Genet Evol, 39, pp.155~162 (2016)[DOI]
- Kang JM, "Population genetic structure and natural selection of Plasmodium falciparum apical membrane antigen-1 in Myanmar isolates", Malar J, 17, pp.71~ (2018)[DOI]
- Pumpaibool T, "Genetic diversity and population structure of Plasmodium falciparum in Thailand, a low transmission country", Malaria J, 8, pp.155~ (2009)[DOI]
- Simpalipan P, "Diversity and population structure of Plasmodium falciparum in Thailand based on the spatial and temporal haplotype patterns of the C-terminal 19-kDa domain of merozoite surface protein-1", Malaria J, 13, pp.54~ (2014)[DOI]
- Vorthon Sawaswong, "Allelic Diversity and Geographical Distribution of the Gene Encoding Plasmodium falciparum Merozoite Surface Protein-3 in Thailand", Parasites, Hosts and Diseases, 53(2), pp.177~187 (2015), 대한기생충학ㆍ열대의학회
- Librado P, "DnaSP v5: a software for comprehensive analysis of DNA polymorphism data", Bioinformatics, 25, pp.1451~1452 (2009)[DOI]
- Kumar S, "MEGA: A biologist-centric software for evolutionary analysis of DNA and protein sequences", Brief Bioinform, 9, pp.299~306 (2008)[DOI]
- Nei M, "Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions", Mol Biol Evol, 3, pp.418~426 (1986)
- Jukes TH, "Mammalian Protein Metabolism", pp.21~132 (1969), Academic Press
- Fu YX, "Statistical tests of neutrality of mutations", Genetics, 133, pp.693~709 (1993)
- Tajima F, "Statistical method for testing the neutral mutation hypothesis by DNA polymorphism", Genetics, 123, pp.585~595 (1989)
- Hudson RR, "Statistical properties of the number of recombination events in the history of a sample of DNA sequences", Genetics, 111, pp.147~164 (1985)
- Excoffier L, "Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows", Mol Ecol Resour, 10, pp.564~567 (2010)[DOI]
- Kocken CH, "Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P-falciparum AMA-1, and antibody-mediated inhibition of red cell invasion", Mol Biochem Parasitol, 109, pp.147~156 (2000)[DOI]
- Conway DJ, "High recombination rate in natural populations of Plasmodium falciparum", Proc Natl Acad Sci USA, 96, pp.4506~4511 (1999)[DOI]
- Kimura M, "The Neutral Theory of Molecular Evolution" (1983), Cambridge University Press
- Coley AM, "Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides", Protein Eng, 14, pp.691~698 (2001)[DOI]
- Coley AM, "The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody", Infect Immun, 74, pp.2628~2636 (2006)[DOI]
- Kato K, "Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx", Proc Natl Acad Sci USA, 102, pp.5552~5557 (2005)[DOI]
- Ellis RD, "Phase 1 study in malaria naive adults of BSAM2", <TEX>$Alhydrogel^{(R)}$<, PLoS One, pp.2012, 7[DOI]
- Laurens MB Kouriba B, "Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine", PLoS One, 12, pp.e0173294~ (2017)[DOI]
- Miura K, "Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1", Infect Immun, 81, pp.1491~1501 (2013)[DOI]
